Day: February 21, 2023

Acronis Featured on CRN’s 2023 Security 100 List for Second Consecutive Year

This exclusive recognition is awarded to industry-leading security vendors in the IT channel making groundbreaking progress within the cybersecurity space CRN’s 2023 Security 100 BURLINGTON, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) — Acronis, a global leader in cyber protection, today announced that CRN®, a brand of The Channel Company, has

GAIN Launches New Strategy to Transform Food Systems

Conflicts, Covid and Climate Change Are Reversing Progress on Malnutrition in Asia NEW DELHI, Feb. 21, 2023 (GLOBE NEWSWIRE) — The Global Alliance for Improved Nutrition (GAIN) today held an open discussion on its new strategy: ‘Healthier Diets For All, Leaving No One Behind!’ The new strategy aims to amplify

Judith Neilson Foundation Gives IAPF US$700,000 to Back Zimbabwe’s Women Wildlife Rangers

PLEASE CREDIT Adrian Steirn. Akashinga ranger Petronella Chigumbura HARARE, Zimbabwe, Feb. 21, 2023 (GLOBE NEWSWIRE) — The International Anti-Poaching Foundation (IAPF) has been awarded a US$700,000 (A$1 million) grant from the Judith Neilson Foundation, which will be used to strengthen its ‘Akashinga – Nature Protected by Women’ program in Zimbabwe.

Envision Pharma Group Hires Industry Leader to Oversee the Expansion of Its Japan Asia-Pacific Regional Business Development and Meet Growing Customer Demand Across the Globe

PHILADELPHIA, Feb. 21, 2023 (GLOBE NEWSWIRE) — Envision Pharma Group (Envision) has appointed Pauline Bernard to the position of Regional Head, Commercial Strategy, Japan Asia-Pacific (JAPAC). Pauline will help drive Envision’s global leadership as a technology-enabled commercialization, data analytics, and integrated medical capabilities and solutions partner to the life sciences

Jowin, the Apple in Korea’s cancer treatment, expands their business globally

Jowin Shinhan Securities IPO Korea’s innovative venture company Jowin declares its expansion into the global cancer care market through the establishment of a global telemedicine platform. A telemedicine platform for overseas patients with stage 4 and terminal cancer will be launched in the first half of this year. It will

Philips continues to demonstrate strong commitment to its ESG ambitions

February 21, 2023 1.81 billion lives improved by Philips’ health technology products, services and solutions Philips became the first health technology company to obtain approval by the Science Based Targets initiative (SBTi) for its entire value-chain CO2 emissions reduction targets, including Scope 1-3 Continued recognition for sustainability leadership – received

Philips publishes its Annual Report 2022

February 21, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2022. Philips’ Annual Report 2022 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 9, 2023. The

Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study

SHANGHAI, China, Feb. 20, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) today announced that the pre-specified interim analysis has been completed for a randomized, double-blind, placebo-controlled, multi-center phase III clinical study (“TORCHLIGHT Study”, NCT04085276) examining the company’s product toripalimab in combination with

Mizar announces its Much-Requested Token Generation Event (TGE)

$MZR LONDON, Feb. 20, 2023 (GLOBE NEWSWIRE) — Following the successful completion of seed and private rounds and 9 figures trading volumes on their copy trading platform, Mizar (MZR Inc) is excited to announce its upcoming Token Generation Event, on 9th March 2023. Since the open Beta release, Mizar has